Mallinckrodt's SpecGx Reports FDA Voted 10-7 To Approve Its Abuse-Deterrent Roxicodone; Committee Voted 12-5 To Label Drug As Abuse-Deterrent By Nasal Route, Voted 10-7 Drug Should Not Be Labeled Abuse-Deterrent By Intravenous Route